Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Reliq Health Technologies Inc V.RHT.H

Alternate Symbol(s):  RQHTF

Reliq Health Technologies Inc. is a global healthcare technology company that specializes in developing virtual care solutions for the healthcare market. The Company’s iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent hospital readmissions and ER visits. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, wound care, and others.


TSXV:RHT.H - Post by User

Comment by theinvestor22on Mar 24, 2022 11:51am
121 Views
Post# 34541643

RE:RE:RE:NEWS - New Contract

RE:RE:RE:NEWS - New ContractThis might not be recurring revenue in the conventional sense, but that hardly matters if the deal with this CRO leads to RHT being involved with many new clinical trials every year, so it could level off at some point and not really go down. 

Also, with so many doctor's offices being involved, this could lead to a great many new contracts with physicians being signed.  So, it might open many doors.  Plus, it might open doors to other clinical trial niches.

throwin wrote:
lscfa wrote: clinical trials are short term and cancer patients expire so how real is it to suggest this is recurring revenue. 

Does Iscfa understand that clinical trials last for years?
Phase 1, Phase 2, Phase 3.
Each phase requires more patients, across many clinics, in multiple cities. Anyone having owned pre- revenue drug companies know how long and intense these trials can be.
Oh, and many, many cancer patients live for years. Chemotherapy, radiation, and recovery from surgery.
Which means being monitored daily. Ever know a loved one who is on chemo?? There are literally a dizzying amount of side effects from these drugs.
Long Reliq!


<< Previous
Bullboard Posts
Next >>